Clinical Trials Browser

INDUSTRY × Cognitive Dysfunction × Clear all

Alzheimer disease type 1, Alzheimer disease type 2, Alzheimer disease type 4, Alzheimer disease, familial, type 3, Alzheimer Disease 9, Alzheimer Disease 8, Alzheimer Disease 11, Alzheimer Disease 7, Alzheimer Disease 6, Alzheimer Disease 10, Alzheimer Disease 5, Alzheimer Disease 15, Alzheimer Disease 14, Alzheimer Disease 13, Alzheimer Disease 12, Alzheimer Disease 16, Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT07563777 2026-05-04

100-Year Human Aging Study

Recruiting

10,000 enrolled

Frailty, Cardiovascular Diseases, Dementia, Musculoskeletal Diseases, Neoplasms, Metabolic Syndrome, Cognitive Dysfunction

NCT06745583 2026-04-09

A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients

Phase 2 Recruiting

15 enrolled

Lymphoid

Neuroinflammatory Diseases, Alzheimer Disease, Lymphoma, Follicular, Neurodegenerative Diseases, Cognitive Dysfunction

NCT05504811 2025-12-24

FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease

Phase NA Completed

31 enrolled

Lymphoid

Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT06245031 2024-05-07

Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)

Phase NA Enrolling by invitation

402 enrolled

Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT05321498 2023-09-28

Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation

Phase 2 Withdrawn

CNS

Alzheimer Disease, Mental Disorders, Brain Diseases, Central Nervous System Diseases, Dementia, Inflammation, Nervous System Diseases, Neurodegenerative Diseases, Tauopathies, Cognitive Dysfunction

NCT05438147 2023-04-26

Effects of a CT-100 DiNaMo Component on Cognitive Functioning and Mood Symptoms

Phase NA Completed

114 enrolled

Multiple Sclerosis, Neoplasms, Cognitive Dysfunction

NCT04972019 2022-05-02

TCIFCF

Phase NA Unknown

40 enrolled

Breast

Breast Neoplasms, Cognitive Dysfunction

NCT04839588 2022-04-28

TCIFCU

Completed

4 enrolled

Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms, Cognitive Dysfunction

NCT03556280 2021-08-24

Overture

Phase NA Active not recruiting

60 enrolled

Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT03661034 2021-08-24

Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)

Phase NA Unknown

20 enrolled

Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular, Memory Disorders, Cognitive Dysfunction

NCT00387062 2008-06-24

Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment

Phase 1 Completed

50 enrolled

Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms, Memory Disorders, Neurobehavioral Manifestations, Cognitive Dysfunction

Clinical Trials

HOPE

100-Year Human Aging Study

A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients

FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease

Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)

Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation

Effects of a CT-100 DiNaMo Component on Cognitive Functioning and Mood Symptoms

TCIFCF

TCIFCU

Overture

Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)

Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment